AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRANEWARE PLC

Notice of Dividend Amount Nov 11, 2016

7581_rns_2016-11-11_9282e702-1e1a-4fcb-8842-614d750194b3.html

Notice of Dividend Amount

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0239P

Craneware plc

11 November 2016

Craneware plc

("Craneware" or the "Company")

Dividend Currency Election

11 November 2016 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 6 September 2016.

For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.25/£1.

For further information, please contact:

Craneware plc

Peel Hunt    

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

George Sellar

Hilary Buchanan

Robyn McConnachie

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCEAKFFFLLKFFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.